Clinical Trial Update: Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating how replacement volume in haemodiafiltration and the oral carbon adsorbent AST-120 affect toxin levels, oxidative stres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• AST-120 (AST-120)

Snippet

Sponsor: Tungs' Taichung Metroharbour Hospital | Conditions: Loss of Solute Clearance | Phase 4 | Status: COMPLETED